BRVE
Common StockBraveheart Bio, Inc.
Reported Shares
21.8M
Position Mix
No options reported
Reported Value
$440.9M
Portfolio Weight
42.36%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$1.0B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
BRVE
Common StockBraveheart Bio, Inc.
Reported Shares
21.8M
Position Mix
No options reported
Reported Value
$440.9M
Portfolio Weight
42.36%
NAMS
Common StockNewAmsterdam Pharma Co N.V.
Reported Shares
8.5M
Position Mix
No options reported
Reported Value
$206.5M
Portfolio Weight
19.84%
KRSA
Common StockKorsana Biosciences, Inc.
Reported Shares
2.2M
Position Mix
No options reported
Reported Value
$70.1M
Portfolio Weight
6.74%
VOR
Common StockVor Biopharma Inc.
Reported Shares
3.4M
Position Mix
No options reported
Reported Value
$65.0M
Portfolio Weight
6.24%
DYN
Common StockDyne Therapeutics, Inc.
Reported Shares
3.6M
Position Mix
No options reported
Reported Value
$57.8M
Portfolio Weight
5.55%
DMRA
Common StockDamora Therapeutics, Inc.
Reported Shares
2.4M
Position Mix
No options reported
Reported Value
$51.9M
Portfolio Weight
4.99%
MPLT
Common StockMapLight Therapeutics, Inc.
Reported Shares
4.4M
Position Mix
No options reported
Reported Value
$45.1M
Portfolio Weight
4.34%
AURA
Common StockAura Biosciences, Inc.
Reported Shares
5.2M
Position Mix
No options reported
Reported Value
$33.0M
Portfolio Weight
3.17%
CBIO
Common StockCRESCENT BIOPHARMA, INC.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$29.5M
Portfolio Weight
2.84%
REPL
Common StockReplimune Group, Inc.
Reported Shares
1.7M
Position Mix
No options reported
Reported Value
$22.8M
Portfolio Weight
2.19%
BCYC
Depositary ReceiptBICYCLE THERAPEUTICS PLC
Reported Shares
3.5M
Position Mix
No options reported
Reported Value
$12.8M
Portfolio Weight
1.23%
TARS
Common StockTarsus Pharmaceuticals, Inc.
Reported Shares
64.1K
Position Mix
No options reported
Reported Value
$5.0M
Portfolio Weight
0.48%
LSTA
Common StockLISATA THERAPEUTICS, INC.
Reported Shares
297.5K
Position Mix
No options reported
Reported Value
$428.4K
Portfolio Weight
0.04%